vector: a market access and development company
TRANSCRIPT
![Page 1: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/1.jpg)
market access
and development company
![Page 2: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/2.jpg)
Dear colleagues, Once there comes a time, when you realize, that your particular knowledge and experience, a quintessence of all your achievements, are able to make something really meaningful. And this is how the story of our company begins. We united professionals in business, international affairs, with legal, medical and educational background from different countries to benefit from the synergy of knowledge and to ensure the access to innovative health technologies in Eastern Europe. Building a bridge between patients, governments, businesses and professional communities we maintain a sustainable development of healthcare market. Collaborating with European Union, Council of Europe and experts from different European institutions, Vector implements the most progressive market access and market development mechanisms. And you’ll find different examples of unprecedented and invincible actions in this presentation. However, we believe, that the most important challenges are still in our future. And I look forward to build successful working relationship with the best manufacturers and distributors of ethical, and patient-oriented health technologies here. Those, interested to share the fundamental European values. With best regards,
Eugeny Nayshtetik MIB, MM, MSoc CEO and co-founder of Vector Ltd
![Page 3: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/3.jpg)
MODERN
DYNAMIC PROFESSIONAL
EUROPEAN INVINCIBLE
CREATIVE
![Page 4: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/4.jpg)
4
Key Ac'vity Areas
PhE and Epi studies Localization of international outcome researches Expert networking and KOL management
Expert Data Research Market access consulting
Licensing and TT Intellectual property rights protection
Business Development
Expert network development Advocacy and awareness raising campaigns CoE Complaint Mechanism Moderation of civic society institutions
Building Competencies International law monitoring
Cross governmental policy adoption Public-private partnership
Framework agreements
Public Affairs
Suppor'ng sustainable development of your business
![Page 5: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/5.jpg)
5
Coopera'on Time Flow
Confidentiality Note
Incoming cooperation proposal
from client
Concept Plan
Signing an Agreement
Specification and Adoption
Invoicing Commercial Annex to the Agreement
Ongoing information support
Market Research
Evaluation Concept Plan Implementation
Final Plan Completion Report
Suppor'ng sustainable development of your business
![Page 6: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/6.jpg)
Facilitate an access to state-of-the-art healthcare technologies
to ensure the fundamental human rights fulfillment
Our Mission
![Page 7: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/7.jpg)
Our Vision
To be reliable and the most confident supplier of market access and market development tools in
Eastern European healthcare systems
![Page 8: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/8.jpg)
Main Values
Life Human Rights
Rule of Law Sustainable Development
![Page 9: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/9.jpg)
Self Policing and Ethics Our activity corresponds and is guided by:
ü IFPMA Code of Practice1
ü Criminal Law Convention on Corruption2
ü Civil Law Convention on Corruption3
ü Ukrainian Act on the Prevention and Combating of
Corruption4
ü US Foreign Corrupt Practices Act (FCPA)5
ü UK Bribery Act 20106
1 hDp://www.ifpma.org/ethics/ifpma-‐code-‐of-‐prac'ce/ifpma-‐code-‐of-‐prac'ce.html 2 hDp://conven'ons.coe.int/Treaty/en/Trea'es/Html/173.htm
3 hDp://conven'ons.coe.int/Treaty/en/Trea'es/Html/174.htm
4 hDp://zakon4.rada.gov.ua/laws/show/3206-‐17 5 hDp://www.jus'ce.gov/criminal/fraud/fcpa/ 6 hDp://www.legisla'on.gov.uk/ukpga/2010/23/contents
![Page 10: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/10.jpg)
portfolio of our achievements
Success Stories
![Page 11: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/11.jpg)
Tuberculosis
![Page 12: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/12.jpg)
Campaign on awareness7,8,9:
ü number of patients increased on 25%
ü adherence to treatment increased on 30%
ü preventive measures have been implemented
Campaign period 2001-‐2007
Market Development Project
7 hDp://tb.org.ua/about.html 8 hDp://www.path.org/projects/tuberculosis_control_in_ukraine_ataglance.php 9 hDp://wwwnc.cdc.gov/eid/ar'cle/12/5/05-‐1103_ar'cle.htm
![Page 13: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/13.jpg)
Gaucher Disease
![Page 14: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/14.jpg)
The most fast-tracking regional program development
in Ukraine with further inclusion into the municipal
budget10:
ü 1 patient has got a treatment in 4 month from the
primary stage only
ü implementation process optimization for International
Cerezyme Access Program in Ukraine
Campaign period 2008-‐2009
Market Development Program
10 Decision of Kharkiv Oblast Council №1076-‐V from 29.01.2009
![Page 15: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/15.jpg)
HIV/AIDS
![Page 16: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/16.jpg)
Campaign on market access 11:
ü Atripla - was included into National HIV program after
market authorization in 2 months
ü Isentress - was included into National HIV program after
market authorization in 12 months
ü Voluntary license on Stocrin (efavirenz) – negotiation
process with local manufacturer was successfully
completed
Campaign period 2010
Market Access Project
11 hDp://zakon4.rada.gov.ua/laws/show/1026-‐17
![Page 17: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/17.jpg)
Vaccina'on
![Page 18: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/18.jpg)
Campaign on market access 12:
ü Gardasil - was included into National Immunization Plan
as a vaccine recommended in 12 months
Campaign period 2011
Market Access Project
ü Prevenar - 7/13 were included into National Immunization Plan as a vaccine recommended in 4 months
12 hDp://zakon4.rada.gov.ua/laws/show/z1159-‐11
![Page 19: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/19.jpg)
Interna'onal Affairs and
GR Campaigns
![Page 20: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/20.jpg)
Campaign period 2013
Comments on RAP/Rcha/UKR/5 This unprecedented project is an attempt to expand
healthcare budget of Ukraine through obligations deriving
from the European Social Charter
The world’s first comment13 on national report on
implementation of the article 11 of the European Social
Charter gave evidence in 3 therapeutic areas :
ü Vaccination
ü Haemophilia
ü Hepatitis C
13 www.coe.int/t/dghl/monitoring/socialcharter/Repor'ng/StateReports/CommentsAllUkrainianCouncil2013_en.pdf
![Page 21: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/21.jpg)
Campaign period 2013
WriDen Declara'on #544 Due to our campaign the first European document, calling the budget reallocation to ensure the fulfillment of human rights in Ukrainian health care system, was assigned: by ‘celebrities’ of European political elite:
ü Jim Dobbin ü Alexander Scrymgeour (The Earl of DUNDEE) ü John Prescott ü Viola von Cramon-Taubadel
by the representatives of: ü 11 National Delegations ü All European political groups ü 10 Committees (of 11) and 12 Sub-committees
(of 20) 14 hDp://assembly.coe.int/ASP/Doc/XrefDocDetails_E.asp?FileID=19932
![Page 22: Vector: a market access and development company](https://reader033.vdocuments.us/reader033/viewer/2022060110/555c8102d8b42a12348b5212/html5/thumbnails/22.jpg)
40-g Frunze St., 3rd entrance, 2nd floor,
Kyiv, 04080, Ukraine +380 50 444 82 74
E-mail: [email protected]
Suppor'ng sustainable development of your business